310 related articles for article (PubMed ID: 19635647)
1. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.
Zhu Y; Hu J; Hu Y; Liu W
Cancer Treat Rev; 2009 Nov; 35(7):590-6. PubMed ID: 19635647
[TBL] [Abstract][Full Text] [Related]
2. Targeting DNA repair as a promising approach in cancer therapy.
Damia G; D'Incalci M
Eur J Cancer; 2007 Aug; 43(12):1791-801. PubMed ID: 17588740
[TBL] [Abstract][Full Text] [Related]
3. Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.
Kinsella TJ
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S42-51. PubMed ID: 19393835
[TBL] [Abstract][Full Text] [Related]
4. DNA repair pathways and their implication in cancer treatment.
Pallis AG; Karamouzis MV
Cancer Metastasis Rev; 2010 Dec; 29(4):677-85. PubMed ID: 20821251
[TBL] [Abstract][Full Text] [Related]
5. DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
Frosina G
Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002
[TBL] [Abstract][Full Text] [Related]
6. Targeting homologous recombination repair defects in cancer.
Evers B; Helleday T; Jonkers J
Trends Pharmacol Sci; 2010 Aug; 31(8):372-80. PubMed ID: 20598756
[TBL] [Abstract][Full Text] [Related]
7. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
Motegi A; Murakawa Y; Takeda S
Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
[TBL] [Abstract][Full Text] [Related]
8. Homologous recombination in cancer development, treatment and development of drug resistance.
Helleday T
Carcinogenesis; 2010 Jun; 31(6):955-60. PubMed ID: 20351092
[TBL] [Abstract][Full Text] [Related]
9. Preclinical perspectives on the use of platinum compounds in cancer chemotherapy.
Farrell NP
Semin Oncol; 2004 Dec; 31(6 Suppl 14):1-9. PubMed ID: 15726528
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic deregulation of DNA repair and its potential for therapy.
Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
[TBL] [Abstract][Full Text] [Related]
11. DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer.
Allinson SL
Future Oncol; 2010 Jun; 6(6):1031-42. PubMed ID: 20528239
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA repair mechanisms in cancer.
Furgason JM; Bahassi el M
Pharmacol Ther; 2013 Mar; 137(3):298-308. PubMed ID: 23107892
[TBL] [Abstract][Full Text] [Related]
13. DNA damage response and development of targeted cancer treatments.
Gasser S
Ann Med; 2007; 39(6):457-64. PubMed ID: 17852036
[TBL] [Abstract][Full Text] [Related]
14. Disparity between DNA base excision repair in yeast and mammals: translational implications.
Kelley MR; Kow YW; Wilson DM
Cancer Res; 2003 Feb; 63(3):549-54. PubMed ID: 12566294
[TBL] [Abstract][Full Text] [Related]
15. Targeting the DNA damage response for cancer therapy.
Powell SN; Bindra RS
DNA Repair (Amst); 2009 Sep; 8(9):1153-65. PubMed ID: 19501553
[TBL] [Abstract][Full Text] [Related]
16. Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy.
Aziz K; Nowsheen S; Pantelias G; Iliakis G; Gorgoulis VG; Georgakilas AG
Pharmacol Ther; 2012 Mar; 133(3):334-50. PubMed ID: 22197993
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy resistance abrogation in metastatic melanoma.
Tawbi HA; Buch SC
Clin Adv Hematol Oncol; 2010 Apr; 8(4):259-66. PubMed ID: 20505649
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors and drug resistance.
Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
[TBL] [Abstract][Full Text] [Related]
19. DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
Ashwell S; Zabludoff S
Clin Cancer Res; 2008 Jul; 14(13):4032-7. PubMed ID: 18593978
[TBL] [Abstract][Full Text] [Related]
20. Targeting SMARCAL1 as a novel strategy for cancer therapy.
Zhang L; Fan S; Liu H; Huang C
Biochem Biophys Res Commun; 2012 Oct; 427(2):232-5. PubMed ID: 22995303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]